Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis

BACKGROUND: Rituximab, a monoclonal antibody that selectively targets CD20-positive B-lymphocytes, is used for the treatment of patients with rheumatoid arthritis (RA) with an inadequate response or tolerance to tumor necrosis factor inhibitors. The objective of this study was to investigate the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasan, Eman, Olusi, Samuel, Al-Awadhi, Adel, Mokaddem, Khalid, Sharma, Prem, George, Sunila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280863/
https://www.ncbi.nlm.nih.gov/pubmed/22355257
http://dx.doi.org/10.2147/BTT.S27840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280863/
https://www.ncbi.nlm.nih.gov/pubmed/22355257
http://dx.doi.org/10.2147/BTT.S27840

Ejemplares similares